As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Pharma companies are separating consumer healthcare businesses to drive growth, facing challenges in a competitive market.

The new US tariff regime, including a 26% reciprocal rate on India, could pressure the Rupee and key export sectors. Read how businesses can ...

Indian stock market opened positively as Nifty 50 rose 0.28% and BSE Sensex increased by 0.29%. The market sentiment improved following hints from the U.S. Federal Reserve about potential interest ...

From Presumed Innocent to Ally McBeal, here are 9 of the best legal dramas and thrillers to add to your watchlist for the ...

Entrepreneurship competition draws over 50,000 applicants each season, culminating in high-stakes outcomes such as 'Most ...

Track Nifty as Trump’s tariff threats shake its recovery, pharma rallies, and metals falter - see how markets may move next.

Pharma and IT stocks gain momentum as Jefferies upgrades Divi’s; market guru Anil Singhvi recommends entry and exit levels ...

Zee Business Managing Editor Anil Singhvi shares his strategy for the coming session on Dalal Street. Learn more about his ...

An analyst from Arihant Capital said that YES Bank is maintaining a lower-top, lower-bottom formation on the daily charts, ...